Location of Thymosin β4 mRNA Expression in Scars and Skins

Zhai Xiaomei,Nie Xingju,Qin Zelian
2007-01-01
Abstract:Objective To investigate the expression of thymosin β4 in the foreskin,normal skin(except the foreskin),hypertrophic scar,and keloid,and its relationship to pathological scars.Methods In situ hybridization was applied to detect the expression of thymosin β4 mRNA [With the probe of BM005698(EST) gene marked by digoxin] in four groups: foreskin,normal skin(except the foreskin),hypertrophic scar,and keloid.Both qualitative and semi-quantitative analysis were performed.Results Thymosin β4 mRNA was expressed in all the four groups.The proportion of thymosin β4 mRNA expression in the keloid was 2/10,which was 25% of that in the foreskin(8/10),and was 28.6% of that in the normal skin(7/10).The positive rate of thymosin β4 mRNA expression in the dermis was higher than that in the epidermis;and was high in fibroblasts,intravascular endothelial cells,and macrophages.The mean OSD of the positive samples was 0.03±0.01 in the keloids,which was significantly lower than that in the normal skins(0.09±0.03) and hypertrophic scars(0.09±0.02)(P=0.000 for both).Compared with the normal skins,the expression increased by 231.5%(P<0.001) in the foreskins(0.30±0.08).The accumulated value of OSD in the four groups was similar to the mean OSD.No significant difference existed in the expression of thymosin β4 mRNA between the normal skins and hypertrophic scars(3/10).However,compared with these two groups,the expression was significantly higher in the foreskins,and significantly lower in the keloids.Conclusions Thymosin β4 mRNA is expressed in both normal skins and scars.The level of expression is decreased in keloids,but is increased in foreskins,indicating that thymosin β4 play a role in keloid formation.
What problem does this paper attempt to address?